Showing results (21-30 of 1,382) with videos related to

Sort By:
Pageof 139
ACS Pharmacology & Translational Science|November 21, 2022
Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in MiceGrant C Glatfelter, Eline Pottie, John S Partilla, et al.
ACS Pharmacology & Translational Science|November 21, 2022
Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical StudiesAnna Liu, Jenny Zhao, Milan Shah, et al.
ACS Pharmacology & Translational Science|November 21, 2022
Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory ChallengeNhu Truong, Christopher C Goodis, Andrea L Cottingham, et al.
ACS Pharmacology & Translational Science|November 21, 2022
Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor SignalingAric Huang, Suresh E Kurhade, Patrick Ross, et al.
ACS Pharmacology & Translational Science|November 21, 2022
The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer AgentsTim Keuler, Carina Lemke, Paul W Elsinghorst, et al.
ACS Pharmacology & Translational Science|June 21, 2021
Metabolism of the Selective Matrix Metalloproteinase-9 Inhibitor (R)-ND-336Charles Edwin Raja Gabriel, Trung T Nguyen, Emanuele Marco Gargano, et al.
ACS Pharmacology & Translational Science|June 21, 2021
Small Molecule Inhibitors of Activation-Induced Deaminase Decrease Class Switch Recombination in B CellsJuan Alvarez-Gonzalez, Adam Yasgar, Robert W Maul, et al.
ACS Pharmacology & Translational Science|June 21, 2021
A Standard Protocol for the Production and Bioevaluation of Ethical In Vivo Models of HPV-Negative Head and Neck Squamous Cell CarcinomaPatrizia Sarogni, Ana Katrina Mapanao, Sabrina Marchetti, et al.
ACS Pharmacology & Translational Science|June 21, 2021
Correction to "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo"Ferah Comert Onder, Nermin Kahraman, Esen Bellur Atici, et al.
ACS Pharmacology & Translational Science|June 21, 2021
Artificial Intelligence Set to Reverse Engineer Drug Targeting in the CellAriel Fernández
Pageof 139